Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > One more look at the new 90 day optimized data

<< Previous

Bullboard Posts

Next >>

Comment by Gooseybearon Apr 29, 2022 7:15am

205 Views

Post# 34641384

RE:RE:RE:RE:RE:One more look at the new 90 day optimized data

I've had T1 NMIBC CIS on and off since 2017 and 20 BCG treatments. I mentioned Ketruda to my Urologist and he said no way, that the side effects are worse than the disease and it should be used for more aggressive treatment.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec